Gene · 5452
Papers3,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico screening of herbal phytochemicals to develop a Rasayana for immunity against Nipah virus. | J Ayurveda Integr Med | 2023 | 38048723 | PubTator, text mining | PubMed |
| A Systems Biology Approach for Investigating Significant Biomarkers and Drug Targets Common Among Patients with Gonorrhea, Chlamydia, and Prostate Cancer: A Pilot Study. | Bioinform Biol Insights | 2023 | 38033384 | PubTator, text mining | PubMed |
| Composite Lymphoma with Follicular Lymphoma Transformation to Clonally Related Epstein-Barr Virus (EBV) Positive Diffuse Large B-Cell Lymphoma and EBV-PositiveClassic Hodgkin Lymphoma. | Case Rep Hematol | 2023 | 38028985 | PubTator, text mining | PubMed |
| Natural killer cell-related prognosis signature predicts immune response in colon cancer patients. | Front Pharmacol | 2023 | 38026928 | PubTator, text mining | PubMed |
| CAR-T Cell Therapy for Classical Hodgkin Lymphoma. | Hemasphere | 2023 | 38026793 | PubTator, text mining | PubMed |
A synergistic investigation of azo-thiazole derivatives incorporating thiazole moieties: a comprehensive exploration of their synthesis, characterization, computational insights, solvatochromism, and multimodal biological activity assessment. | RSC Adv | 2023 | 38024963 | PubTator, text mining | PubMed |
| The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas. | Front Oncol | 2023 | 38023160 | PubTator, text mining | PubMed |
| Catch the Calcium: T-Cell Histiocyte-Rich B-Cell Lymphoma Presenting as Hypercalcemia. | World J Oncol | 2023 | 38022410 | PubTator, text mining | PubMed |
| The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndrome. | Nat Commun | 2023 | 37996443 | PubTator, text mining | PubMed |
| CellGO: a novel deep learning-based framework and webserver for cell-type-specific gene function interpretation. | Brief Bioinform | 2023 | 37995133 | PubTator, text mining | PubMed |
| Wnt Signaling and Therapeutic Resistance in Castration-Resistant Prostate Cancer. | Curr Pharmacol Rep | 2023 | 37994344 | PubTator, text mining | PubMed |
| Bioinformatics strategies to identify differences in molecular biomarkers for ischemic stroke and myocardial infarction. | Medicine (Baltimore) | 2023 | 37986378 | PubTator, text mining | PubMed |
| Recent advances on high-efficiency of microRNAs in different types of lung cancer: a comprehensive review. | Cancer Cell Int | 2023 | 37986065 | PubTator, text mining | PubMed |
| Longitudinal multi-functional analysis identified responses of T cells, B cells, and monocytes as hallmarks of immunotherapy tolerance in patients with merkel cell carcinoma. | PLoS One | 2023 | 37983224 | PubTator, text mining | PubMed |
| Population pharmacokinetic and exposure-response analyses of pemigatinib in patients with advanced solid tumors including cholangiocarcinoma. | CPT Pharmacometrics Syst Pharmacol | 2023 | 37969064 | PubTator, text mining | PubMed |
| Resequencing of the TMF-1 (TATA Element Modulatory Factor) regulated protein (TRNP1) gene in domestic and wild canids. | Canine Med Genet | 2023 | 37968761 | PubTator, text mining | PubMed |
| Stereoselective Inhibition of High- and Low-Affinity Organic Cation Transporters. | Mol Pharm | 2023 | 37962560 | PubTator, text mining | PubMed |
| Comprehensive analysis of HDAC7 expression and its prognostic value in diffuse large B cell lymphoma: A review. | Medicine (Baltimore) | 2023 | 37960766 | PubTator, text mining | PubMed |
| The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant. | Int J Mol Sci | 2023 | 37958914 | PubTator, text mining | PubMed |
| Identification of genetic biomarkers, drug targets and agents for respiratory diseases utilising integrated bioinformatics approaches. | Sci Rep | 2023 | 37925496 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5452/papers?page=12